Elevance Health, Inc. (ELV)

Over the past six months, Elevance Health's stock (ELV) has experienced a decline. As of June 27, 2025, the share price was $381.49, representing a decline of 29.60% from June 28, 2024, when it was $541.86. The stock was down 29.1% over the past six months and 27.24% over the past 12 months as of June 30, 2025. Despite this, ELV's stock has risen by 3.49% compared to the previous week and 2.38% over the last month as of December 18, 2024. In the past three months, ELV shares have marginally declined, outperforming the iShares U.S. Healthcare Providers ETF (IHF). A notable event impacting the stock was the release of its Q4 and full-year 2024 results on January 23, 2025, following which the company's stock surged by 2.7%. Elevance Health reported a 6% increase in operating revenue, reaching $45 billion for the fourth quarter of 2024, and its earnings per share (EPS) of $3.84 surpassed Wall Street estimates by 1.1%.

Elevance Health's demand seasonality is influenced by factors within its health benefits and pharmacy services segments. Part D seasonality is expected to resemble its medical benefits business. The company has observed a more front-loaded earnings contribution due to shifts in membership mix, with over 60% of earnings expected in the first half of the year. There is strong engagement with integrated offerings in the commercial sector.

Elevance Health, Inc. is an American for-profit health benefits company in the Healthcare sector, specifically in the Healthcare Plans industry. The company provides a range of health insurance services and plans, including medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Elevance Health also offers specialty products and fee-based administrative managed care services. Through Carelon, it provides pharmacy benefit management (PBM) services (CarelonRx) and care delivery solutions. The company emphasizes a "whole health" approach, integrating digital health solutions, wellness programs, and personalized healthcare solutions. Elevance Health serves approximately 47 million medical members through employer, individual, and government-sponsored coverage plans.

Elevance Health has a significant geographic footprint across the United States. It operates as the exclusive licensee of the Blue Cross Blue Shield brand in 14 states, holding a number-one or number-two membership position in all of them. Through its affiliated companies and diverse services, Elevance Health serves approximately 119 million individuals in 26 states. The company has strategically expanded its reach through acquisitions, such as MMM Holdings, LLC in Puerto Rico in 2021, and Integra Managed Care in New York in 2022. In January 2023, Elevance announced the acquisition of Blue Cross and Blue Shield of Louisiana, which would further expand its footprint to 15 states and add 1.9 million new members. Additionally, the acquisition of Paragon Healthcare, Inc. in March 2024, specializing in infusion services, expanded Elevance Health's capabilities and geographic presence in this area, with Paragon Healthcare operating over 40 ambulatory infusion centers across eight states.

Elevance Health has a strong brand reputation due to its strategic transformation and consistent financial performance. The company rebranded from Anthem, Inc. to Elevance Health, Inc. in June 2022, focusing on "elevating whole health." Elevance Health leverages the Blue Cross Blue Shield brand as the exclusive licensee in 14 states. The company has demonstrated strong financial performance, with total operating revenue exceeding $171 billion for fiscal year 2023. In 2023, Elevance Health was listed in Fortune magazine's "100 Best Companies to Work For®".

Elevance Health's ownership is distributed among institutional, retail, and individual investors. Approximately 76.61% of the company's stock is owned by Institutional Investors, 0.14% by Insiders, and 23.25% by Public Companies and Individual Investors. Major institutional owners and shareholders include Vanguard Group Inc., BlackRock, Inc., State Street Corp, Price T Rowe Associates Inc /md/, Wellington Management Group Llp, Capital International Investors, Geode Capital Management, Llc, and Sanders Capital, LLC. Vanguard Group Inc. is the largest individual shareholder, holding 9.80% of the company's shares.